Literature DB >> 31314950

A comparison study of different decellularization treatments on bovine articular cartilage.

Toktam Ghassemi1, Nasser Saghatoleslami1, Nasser Mahdavi-Shahri2, Maryam M Matin2, Reza Gheshlaghi1, Ali Moradi3.   

Abstract

Previous researches have emphasized on suitability of decellularized tissues for regenerative applications. The decellularization of cartilage tissue has always been a challenge as the final product must be balanced in both immunogenic residue and mechanical properties. This study was designed to compare and optimize the efficacy of the most common chemical decellularization treatments on articular cartilage. Freeze/thaw cycles, trypsin, ethylenediaminetetraacetic acid (EDTA), sodium dodecyl sulfate (SDS), and Triton-X 100 were used at various concentrations and time durations for decellularization of bovine distal femoral joint cartilage samples. Histological staining, scanning electron microscopy, DNA quantification, compressive strength test, and Fourier-transform infrared spectroscopy were performed for evaluation of the decellularized cartilage samples. Treatment with 0.05% trypsin/EDTA for 1 day followed by 3% SDS for 2 days and 3% Triton X-100 for another 2 days resulted in significant reduction in DNA content and simultaneous maintenance of mechanical properties. Seeding the human adipose-derived stem cells onto the decellularized cartilage confirmed its biocompatibility. According to our findings, an optimized physiochemical decellularization method can yield in a nonimmunogenic biomechanically compatible decellularized tissue for cartilage regeneration application.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  articular cartilage; chemical detergents; decellularization; extracellular matrix (ECM); optimization; tissue engineering

Year:  2019        PMID: 31314950     DOI: 10.1002/term.2936

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  7 in total

Review 1.  Preparation and Application of Decellularized ECM-Based Biological Scaffolds for Articular Cartilage Repair: A Review.

Authors:  Qian Zhang; Yixin Hu; Xuan Long; Lingling Hu; Yu Wu; Ji Wu; Xiaobing Shi; Runqi Xie; Yu Bi; Fangyuan Yu; Pinxue Li; Yu Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-30

Review 2.  Biochemical Aspects of Scaffolds for Cartilage Tissue Engineering; from Basic Science to Regenerative Medicine.

Authors:  Davood Yari; Mohammad H Ebrahimzadeh; Jebrail Movaffagh; Azadeh Shahroodi; Moein Shirzad; Durdi Qujeq; Ali Moradi
Journal:  Arch Bone Jt Surg       Date:  2022-03

Review 3.  Decellularization for the retention of tissue niches.

Authors:  Deana Moffat; Kaiming Ye; Sha Jin
Journal:  J Tissue Eng       Date:  2022-05-21       Impact factor: 7.940

Review 4.  Applications of Vibrational Spectroscopy for Analysis of Connective Tissues.

Authors:  William Querido; Shital Kandel; Nancy Pleshko
Journal:  Molecules       Date:  2021-02-09       Impact factor: 4.411

5.  Cartilage Formation In Vivo Using High Concentration Collagen-Based Bioink with MSC and Decellularized ECM Granules.

Authors:  Elena V Isaeva; Evgeny E Beketov; Grigory A Demyashkin; Nina D Yakovleva; Nadezhda V Arguchinskaya; Anastas A Kisel; Tatiana S Lagoda; Egor P Malakhov; Anna N Smirnova; Vasiliy M Petriev; Petr S Eremin; Egor O Osidak; Sergey P Domogatsky; Sergey A Ivanov; Petr V Shegay; Andrey D Kaprin
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 6.  Three-dimensional bio-printing of decellularized extracellular matrix-based bio-inks for cartilage regeneration: a systematic review.

Authors:  Melika Sahranavard; Soulmaz Sarkari; SeyedehMina Safavi; Farnaz Ghorbani
Journal:  Biomater Transl       Date:  2022-06-28

7.  An in vitro investigation to understand the synergistic role of MMPs-1 and 9 on articular cartilage biomechanical properties.

Authors:  Allison Mixon; Andrew Savage; Ahmed Suparno Bahar-Moni; Malek Adouni; Tanvir Faisal
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.